[PDF][PDF] Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases
KE Rusthoven, BD Kavanagh, SH Burri… - Journal of Clinical …, 2009 - researchgate.net
KE Rusthoven, BD Kavanagh, SH Burri, C Chen, H Cardenes, MA Chidel, TJ Pugh, M Kane…
Journal of Clinical Oncology, 2009•researchgate.netMulti-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Lung Metastases
Page 1 Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Lung
Metastases Kyle E. Rusthoven, Brian D. Kavanagh, Stuart H. Burri, Changhu Chen, Higinia
Cardenes, Mark A. Chidel, Thomas J. Pugh, Madeleine Kane, Laurie E. Gaspar, and Tracey
E. Schefter From the University of Colorado Denver, Departments of Radiation Oncology and
Medical Oncology, Aurora; St Joseph’s Hospital Radiation Oncology, Denver, CO; Carolinas …
Page 1 Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Lung
Metastases Kyle E. Rusthoven, Brian D. Kavanagh, Stuart H. Burri, Changhu Chen, Higinia
Cardenes, Mark A. Chidel, Thomas J. Pugh, Madeleine Kane, Laurie E. Gaspar, and Tracey
E. Schefter From the University of Colorado Denver, Departments of Radiation Oncology and
Medical Oncology, Aurora; St Joseph’s Hospital Radiation Oncology, Denver, CO; Carolinas …
Purpose
To evaluate the efficacy and tolerability of high-dose stereotactic body radiation therapy (SBRT) for the treatment of patients with one to three lung metastases.
researchgate.net